Alexander Introduces Pharmaceutical Compounding Legislation

Wednesday, May 15, 2013

Chairman of the Senate Health, Education, Labor and Pensions Committee Senator Tom Harkin (D-Iowa) and Ranking Member Lamar Alexander (R-Tn.), with Senators Pat Roberts (R-Ks.) and Al Franken (D-Mn.) and other members of the HELP Committee, on Wednesday introduced legislation—the Pharmaceutical Compounding Quality and Accountability Act—that would improve the safety of compounded human and animal drugs by making clear the compounding oversight responsibilities of state and federal authorities. 

Chairman Harkin and Ranking Member Alexander also announced that the Committee will convene for an executive session next Wednesday, to consider the compounding bill, along with newly-introduced legislation to strengthen and improve the drug distribution supply chain.

In April, Senators Harkin, Alexander, Roberts, and Franken released draft legislation relating to pharmaceutical compounding and requested that stakeholders provide feedback on the policy merits, potential unintended consequences, and opportunities to improve the legislative language. Additionally, the HELP Committee held a legislative hearing in early May to listen to more in-depth testimonies from experts and stakeholders to improve the draft bill.  An updated one-pager, section-by-section and the Pharmaceutical Compounding Quality and Accountability Act can be viewed on the HELP Committee website.

The Pharmaceutical Compounding Quality and Accountability Act makes a clear distinction between traditional compounding—which will continue to be regulated primarily by state pharmacy boards—and compounding manufacturers that make sterile products without, or in advance of, a prescription and sell those products across state lines. The compounding manufacturers would be regulated by the U.S. Food and Drug Administration (FDA). It clarifies a national, uniform set of rules for compounding manufacturers while preserving the states’ primary role in traditional pharmacy regulation.

“We cannot wait for the next public health crisis—as we saw with the New England Compounding Company disaster that led to more than 50 deaths and caused serious illness in 700 more—to act to improve the safety of compounded drugs,” Chairman Harkin said. “The Pharmaceutical Compounding Quality and Accountability Act will help protect the public from unsafe compounded products and clarify FDA authority over high-risk compounding practices. I am proud of the bipartisan effort that members of this Committee have put forth in drafting this bill, and I am appreciative of the helpful and constructive feedback received from stakeholders throughout this process. I look forward to considering this bill in an executive session of the Committee next week.”

Senator Alexander said, “My primary goal with this legislation is to erase the confusion over who regulates pharmacies and manufacturing facilities, and make it clear exactly who oversees each business. Putting one agency on the flagpole for each of these businesses will mean greater safety for American families, so they don’t have to question whether the drugs they take are safe.”

“I am proud of the work we have done to craft a solution that protects patients, while preserving the practice of traditional pharmacy compounding,” Senator Roberts said. “After reviewing stakeholder comments, we made a concerted effort to address their concerns in this legislation. This bipartisan bill is balanced, clear and will leave no questions about the regulatory oversight of compounded drugs. I urge my colleagues to support it.”

"We've seen far too many deaths in Minnesota, and nationwide, because some pharmacies in this country have acted more like drug manufacturers – without following rigorous safety rules that drug manufacturers must follow,” said Senator Franken. “This bipartisan legislation will keep Minnesotans safe by ensuring that drug manufacturers have appropriate oversight, and that responsible pharmacies don't see any unnecessary restrictions."

In addition to distinguishing between pharmacies and manufacturers, and clarifying proper oversight of each, the legislation sets forth requirements on compounding manufacturers. Compounding manufacturers must register with the FDA and tell the agency what products they have made; make products under a pharmacist’s oversight and in compliance with good manufacturing practices; and investigate and report when things go wrong.

The bill allows FDA to identify categories of drugs that currently cannot be safely compounded; preserves and enhances current protections regarding the ingredients from which drugs are compounded; and preserves the line between compounding manufacturers and traditional manufacturers by placing prohibitions on wholesale distribution of compounded products.

The legislation also encourages communication among states and increases communication between states and the FDA. FDA will designate a point of contact for a State Board of Pharmacy to notify the agency if it appears that a state-licensed business should be registered as a compounding pharmacy. The FDA must notify the state within 15 days if it determines that business is a compounding manufacturer.


Blood Assurance Says Stay Cool With Fourth Of July Giveaway

Community members who make an appointment to donate at any Blood Assurance donor center, bloodmobile, or blood drive between July 1-8 will receive a Fourth of July cooler. This complimentary gift is a part of Blood Assurance’s goal to save 90,000 lives this summer – a time when blood supply levels are historically low. “We are always in need of blood and platelet donations, ... (click for more)

Siskin Hospital Therapist Earns Certification

Siskin Hospital announces Carroll Allen, PT, has passed the Geriatric Certified Specialist exam.   This certification is awarded by the American Physical Therapy Association.   Ms. Allen is a physical therapist in Siskin Hospital’s Outpatient Orthopedic Program.   The Geriatric Certified Specialist certification is for physical therapists with advanced clinical ... (click for more)

Smith Denies He Told Young To Shoot Holsey In North Chattanooga Drug Deal That Cost A Life; Asks Jury To Spare Him Life Sentence

Briston "B.J." Smith told a Criminal Court jury on Friday afternoon that he never ordered Adram "A.B." Young to shot Charles "Chas" Holsey in a North Chattanooga drug deal that cost a life. Smith, who was 18 at the time and is now 20, asked the jury not to put him behind bars for life. The state is seeking a life sentence (51 years) on a first-degree felony murder charge. ... (click for more)

12 "Johns" Arrested In Multi-Agency Prostitution Sting Operation In East Ridge, Including Doctor, Teacher

A joint operation was conducted on Wednesday by the East Ridge Police Department in cooperation with the Hamilton County Sheriff’s Department, Chattanooga Police Department, and the Tennessee Bureau of Investigation to combat human trafficking and prostitution complaints within the city of East Ridge. The operation was conducted over a two-day period when online advertisements ... (click for more)

Exempt Volunteer Fire Departments From Procurement Policies - And Response

The Hamilton County Commission just grouped a bunch of departments together in an attempt to reign in the CVB. I haven't spoken to any commissioners, but I truly believe it was unknowingly. By mandating that all non profits that receive 25 percent of their revenue follow county procurement policies, they might as well have padlocked all local volunteer fire departments. We expect ... (click for more)

Roy Exum: Luther’s B-17 Showed Up

I am a huge sap for our veterans and just the other days a reader shared the ultimate story about a guy who returned to his sweetheart at the end of World War II. The little town of Miller. Missouri, is located in the southwest corner of the state and the biggest thing to ever happen in Lawrence County is when a native son, James Lawrence, hollered “Don’t Give Up The Ship” in the ... (click for more)